Volltext-Downloads (blau) und Frontdoor-Views (grau)
  • search hit 2 of 2
Back to Result List

Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-34970

A Biomarker for Alzheimer’s Disease Based on Patterns of Regional Brain Atrophy

  • Introduction: It has been shown that Alzheimer’s disease (AD) is accompanied by marked structural brain changes that can be detected several years before clinical diagnosis via structural magnetic resonance (MR) imaging. In this study, we developed a structural MR-based biomarker for in vivo detection of AD using a supervised machine learning approach. Based on an individual’s pattern of brain atrophy a continuous AD score is assigned which measures the similarity with brain atrophy patterns seen in clinical cases of AD. Methods: The underlying statistical model was trained with MR scans of patients and healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-1 screening). Validation was performed within ADNI-1 and in an independent patient sample from the Open Access Series of Imaging Studies (OASIS-1). In addition, our analyses included data from a large general population sample of the Study of Health in Pomerania (SHIP-Trend). Results: Based on the proposed AD score we were able to differentiate patients from healthy controls in ADNI-1 and OASIS-1 with an accuracy of 89% (AUC = 95%) and 87% (AUC = 93%), respectively. Moreover, we found the AD score to be significantly associated with cognitive functioning as assessed by the Mini-Mental State Examination in the OASIS-1 sample after correcting for diagnosis, age, sex, age·sex, and total intracranial volume (Cohen’s f2 = 0.13). Additional analyses showed that the prediction accuracy of AD status based on both the AD score and the MMSE score is significantly higher than when using just one of them. In SHIP-Trend we found the AD score to be weakly but significantly associated with a test of verbal memory consisting of an immediate and a delayed word list recall (again after correcting for age, sex, age·sex, and total intracranial volume, Cohen’s f2 = 0.009). This association was mainly driven by the immediate recall performance. Discussion: In summary, our proposed biomarker well differentiated between patients and healthy controls in an independent test sample. It was associated with measures of cognitive functioning both in a patient sample and a general population sample. Our approach might be useful for defining robust MR-based biomarkers for other neurodegenerative diseases, too.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar

Statistics

frontdoor_oas
Metadaten
Author: Stefan Frenzel, Katharina Wittfeld, Mohamad Habes, Johanna Klinger-König, Robin Bülow, Henry Völzke, Hans Jörgen Grabe
URN:urn:nbn:de:gbv:9-opus-34970
DOI:https://doi.org/10.3389/fpsyt.2019.00953
ISSN:1664-0640
Parent Title (English):Frontiers in Psychiatry
Publisher:Frontiers Media S.A.
Document Type:Article
Language:English
Date of first Publication:2020/01/14
Release Date:2020/10/12
Tag:Alzheimer's disease; FreeSurfer; dementia; machine learning; magnetic resonance imaging
GND Keyword:-
Volume:10
Faculties:Universitätsmedizin / Klinik für Psychiatrie und Psychotherapie
Licence (German):License LogoCreative Commons - Namensnennung